Provided by Tiger Trade Technology Pte. Ltd.

Mineralys Therapeutics, Inc.

28.05
+0.51001.85%
Volume:763.52K
Turnover:21.90M
Market Cap:2.47B
PE:-6.41
High:29.52
Open:28.03
Low:27.95
Close:27.54
52wk High:47.65
52wk Low:22.30
Shares:88.16M
Float Shares:66.03M
Volume Ratio:0.60
T/O Rate:1.16%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-4.3763
EPS(LYR):-2.2900
ROE:-80.88%
ROA:-46.18%
PB:4.49
PE(LYR):-12.25

Loading ...

Feb 13, 2024

Beneficial Ownership Change

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
Feb 13, 2024

Beneficial Ownership Change

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
Feb 12, 2024

Beneficial Ownership Change

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
Feb 12, 2024

Beneficial Ownership Change

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
Feb 08, 2024

Major Issues Report

Form 8-K - Current report
Jan 04, 2024

Major Issues Report

Form 8-K - Current report
Dec 22, 2023

Major Issues Report

Form 8-K - Current report
Nov 13, 2023

Major Issues Report

Form 8-K - Current report
Nov 08, 2023

Major Issues Report

Form 8-K - Current report
Nov 07, 2023

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Nov 02, 2023

Major Issues Report

Form 8-K - Current report
Sep 15, 2023

Major Issues Report

Form 8-K - Current report
Aug 11, 2023

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Aug 10, 2023

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Aug 08, 2023

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Aug 08, 2023

Major Issues Report

Form 8-K - Current report
Jul 17, 2023

Major Issues Report

Form 8-K - Current report
May 15, 2023

Major Issues Report

Form 8-K - Current report
May 15, 2023

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
May 02, 2023

Major Issues Report

Form 8-K - Current report